Searchable abstracts of presentations at key conferences in endocrinology

ea0032p484 | Diabetes | ECE2013

Copeptin: may it be a novel biomarker for insulin theraphy in subjects with diabetes?

Harman Ece , Dodurga Yavuz , Gundogdu Gulsah , Ayada Ceylan , Erken Gulten , Kucukatay Vural , Avci Cigir Biray , Genc Osman

Background and aim: As a prognostic marker, copeptin levels were independent predictors of survival in critically ill patients suffering from hemorrhagic and septic shock. Copeptin levels also have prognostic implications in chronic diseases other than acute illness. The stress-mediated activation of the HPA axis may be have role in the pathogenesis of the insulin resistance, metabolic syndrome, and diabetes. Furthermore, AVP action has been linked to liver glycogenolysis and ...